HEPATOTOXIC EFFECTS DUE TO THE COMBINED CONSUMPTION OF OPIOID DRUGS AND ALCOHOL
ARTICLE PDF

Keywords

drug poisoning
methadone
alcohol
hepatotoxicity

How to Cite

Kurdil, N. V., Palamar, B. I., Lisovska, V. S., Zhminko, P. G., Balan, H. M., & Andryushchenko, V. V. (2024). HEPATOTOXIC EFFECTS DUE TO THE COMBINED CONSUMPTION OF OPIOID DRUGS AND ALCOHOL. Clinical and Preventive Medicine, (4), 72-77. https://doi.org/10.31612/2616-4868.4.2024.10

Abstract

Introduction. Over the past 20 years, opioid consumption in the world has reached epidemic proportions, which has led to an increase in premature mortality and significantly changed the epidemiology of liver diseases.

Aim. The study of features of liver injury with combined consumption of opioid drugs and alcohol.

Materials and methods. A retrospective analysis of the medical data of 1,540 patients with the diagnoses of "Acute narcotic poisoning" and "Acute methadone poisoning" (ICD-10:Т40.0-Т40.3); 42 acts of forensic medical and forensic histological examination of death cases associated with illegal methadone and alcohol were considered. Clinical, biochemical, and pathohistological studies were used. Histological samples were examined using an Olympus CX 41 microscope in transmitted light, at magnifications of 100, 200, and 400 times. The SPSS Statistics 29.0.0.0 program was used, Pearson's correlation analysis was used, p≤0.05.

Results. According to the results of forensic and histological studies, pronounced infiltration of the liver tissue by small lymphocytes (r=0.471, р=0.002) was found in persons with a long history of illegal methadone and alcohol consumption, which was combined with portal fibrosis (r=0.333, р=0.021) and, in some cases, moderate proliferation of bile ducts (r=0.203, p=0.047). Morphometric analysis of liver biopsies revealed sinusoidal dilatation, inflammatory and fibrotic changes of the terminal hepatic venules (r=0.501, p=0.017); sclerotic changes were noted from the expansion of the portal tracts due to fibrosis and to the initial signs of a partial structure violation, which indicates the transition to cirrhosis.

Conclusions. The progressive spread of the practice of combined consumption of opioid drugs on the example of methadone and alcohol increases the risk of hepatotoxic effects, in particular, accelerating the development of fibrosis and cirrhosis.

https://doi.org/10.31612/2616-4868.4.2024.10
ARTICLE PDF

References

Verna EC, Schluger A, Robert S, Brown RS. Opioid epidemic and liver disease. JHEP Rep. 2019 Sep; 1(3): 240–255. DOI: 10.1016/j.jhepr.2019.06.006

Kardashian A, Serper M, Terrault N, Nephew LD. Health disparities in chronic liver disease. Hepatology. 2023 Apr; 77(4): 1382–1403. DOI: 10.1002/hep.32743

Soleimanpour H, Safari S, Shahsavari Nia K, Sanaie S, Alavian SM. Opioid Drugs in Patients With Liver Disease: A Systematic Review. Hepat Mon. 2016 Mar 6;16(4):e32636. DOI: 10.5812/hepatmon.32636

Jover R, Ponsoda X, Gómez-lechón MJ, Castell JV. Potentiation of heroin and methadone hepatotoxicity by ethanol: an in vitro study using cultured human hepatocytes. Xenobiotica. 1992;22:471-478. DOI: 10.3109/00498259209046659

Amraei M, Mohamadpour M, Reza Hafezi Ahmadi M, Azizi M, Daemi A, Omidi M, Shirzadpour E. Histopathological study of liver tissue due to methadone consumption and its effect on liver enzymes and inflammatory indices in rat. Drug Des Devel Ther. 2018 Nov 5:12:3785-3795. DOI: 10.2147/DDDT.S182032

Dinis-Oliveira RJ. Metabolomics of methadone: clinical and forensic toxicological implications and variability of dose response. Drug Metab Rev. 2016;48(4):568–576. DOI: 10.1080/03602532.2016.1192642

Otto AO, Rivera CG, Zeuli JD, Temesgen Z. Hepatotoxicity of Contemporary Antiretroviral Drugs: A Review and Evaluation of Published Clinical Data. Cells. 2021 May 20;10(5):1263. DOI: 10.3390/cells10051263

Tang B, Zhang Y, Liang R, Yuan P, Du J, Wang H, Wang L. Activation of the delta-opioid receptor inhibits serum deprivation-induced apoptosis of human liver cells via the activation of PKC and the mitochondrial pathway. Int J Mol Med. 2023 Jun;51(6):51. DOI: 10.3892/ijmm.2023.5254

Dennis BB, Akhtar D, Cholankeril G, Kim D, Sanger N, Hillmer A, et al. The impact of chronic liver disease in patients receiving active pharmacological therapy for opioid use disorder: One-year findings from a prospective cohort study. Multicenter Study. Drug Alcohol Depend. 2020 Apr 1:209:107917. DOI: 10.1016/j.drugalcdep.2020.107917

Chalabianloo F, Høiseth G, Vold JH, Johansson KA, Kringen MK, Dalgard O, et al. Impact of liver fibrosis and clinical characteristics on dose-adjusted serum methadone concentrations. J Addict Dis. 2023 Jan-Mar;41(1):53-63. DOI: 10.1080/10550887.2022.2057140

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.